Indication

Erysipeloid

Erysipeloid is an acute cutaneous bacterial zoonosis caused by inoculation with *Erysipelothrix rhusiopathiae*, a Gram-positive bacillus. Read more about Erysipeloid

16 drugs 12 manufacturers

Advertisement

Drugs that treat it

Common Erysipeloid therapies.

Showing 10–16 of 16 drugs

Filter & compare in the drug finder →Opens the drug finder with Erysipeloid preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Erysipeloid.

Erysipeloid is an acute cutaneous bacterial zoonosis caused by inoculation with *Erysipelothrix rhusiopathiae*, a Gram-positive bacillus.

It primarily affects the skin of individuals with occupational exposure to contaminated animals, poultry, meat, fish, or shellfish, typically gaining entry through microtrauma or abrasions on the hands or fingers.

Pathophysiologically, localized bacterial proliferation produces a tender, well-demarcated, violaceous or reddish plaque with sharp, slightly elevated borders that slowly spreads outward, often accompanied by local edema, warmth, and burning.

While predominantly manifesting as a self-limiting local infection, the pathogen can occasionally progress to a diffuse cutaneous form or produce systemic bacteremia with a high propensity for infective endocarditis.

Personalize your experience

Follow Erysipeloid and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it